PROVIDER PROFILE · NPI 1003354135

Guixin DuPA-C

PRESCRIBING · PART D · 2024
Total Rx claims
358
Beneficiaries
Total drug cost
$34K
Distinct drugs
13
Brand share
20.4%
Top prescribed drugs
Naproxen44 claims
Mirabegron38 claims
Finasteride38 claims
QUALITY · MIPS · 2024
Final MIPS score
80.0
Quality
75.7
Cost
72.3
Improvement activities
40.0
Promoting interop.
78.0
Payment adjustment
0.21%
Group
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

Hospital